Release Date: 03/04/19 10:41 Summary: Appointment of Karl Trouchet to new Strategy role Price Sensitive: No Download Document 145.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%